BioVision Lilly Award to honour scientists from developing countries

Prize will reward research into infectious diseases

BioVision and TWAS, the academy of sciences for the developing world, will honour outstanding scientific achievements made by individual young scientists from developing countries in the BioVision Lilly Award.

The prize will reward three young scientists living and working in a developing country, who have a track record of excellent research in infectious diseases, preferably with an emphasis on tuberculosis, and promise to have a positive impact in the developing world.

Candidates should be under 40 and hold at least a PhD.

Three winners will be selected and invited to attend BioVision 2011 in Lyon, France from 27-29 March.

The winner will receive US$5,000 and the runner-up $2,000, to be used for his or her research. The third prizewinner will receive an invitation to attend BioVision 2011, with travel and hotel costs paid.

The awards will be presented at a ceremony hosted by BioVision, TWAS and Lilly, during the exhibition.

The closing date for nominations is 15 January 2011.

You may also like

Regulatory

TurboFil debuts latest generation of through-the-tip benchtop syringe filler

TipFil Plus provides precise, aseptic-ready filling and capping for lab and pharmacy applications
Manufacturing

Concentrating recombinant proteins for drug discovery using centrifugal evaporation

Exploring purification, concentration and sample protection in recombinant protein workflows
Research & Development

COVID-19 immunity lowers the risk of a new pandemic

Researchers at the MRC-University of Glasgow Centre for Virus Research have demonstrated that the likelihood of the emergence of a new SARS-type virus pandemic has been significantly reduced by population-wide immunity to SARS-CoV-2
You need to be a subscriber to read this article.
Click here to find out more.
Research & Development

Cytiva enters research partnership with SRTIGET for next-gen genomic medicine

The pair aim to expand the role of lipid nanoparticle technology into gene therapy delivery, including applications in cancer and inherited blood diseases, CNS delivery for neurological disorders where current methods fail and in vivo stem cell modification that could eliminate toxic conditioning regimens
Research & Development

Shimadzu’s Design Craftech

Fusing traditional Kyoto craft techniques with industrial production
Research & Development

Just – Evotec Biologics wins BARDA contract to optimise antibody biomanufacturing against Ebola and Sudan virus

Just – Evotec Biologics has been selected by BARDA to develop scalable, high-yield manufacturing processes for a monoclonal antibody cocktail targeting filovirus diseases under a multi-year programme valued at up to $10m
Research & Development

ProImmune and Roslin Institute collaborate to develop species-specific Ankyron binders for veterinary immunology

Immunological reagents specialist ProImmune has partnered with the University of Edinburgh's Roslin Institute to generate and validate novel species-specific binding proteins for porcine, bovine, avian and salmonid research, addressing a critical shortage of high-quality veterinary immunology reagents
Subscribe now